StockDriftsStockDriftsTop 3 Mv Management Xi, L.l.c. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ROVR | ROVER GROUP INC | 89.96% | 8.64M | $54.1M | +0.00%(+0) | — | 2023-09-30 | |
| RXRX | RECURSION PHARMACEUTICALS IN | 10.04% | 788.8K | $6.0M | -60.00%(-1.18M) | — | 2023-09-30 | |
| ANGI | ANGI INC | 0.01% | 1.9K | $4K | +0.00%(+0) | — | 2023-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Mv Management Xi, L.l.c. reports $60.11M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are ROVR (90.0%), RXRX (10.0%) and ANGI (0.0%). Figures reflect the Q3 2023 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Mv Management Xi, L.l.c., compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Mv Management Xi, L.l.c.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1503556). View Mv Management Xi, L.l.c.’s 13F filings on SEC